51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3 反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 2 H,70 °C; 1 H,70 - 75 °C; 1 H,75 °C -> 65 °C; 2 H,60 °C; 60 °C -> 25 °C; 12 H,25 °C 标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Ylmethanol And (R)-2-[3-(Diisopropylamino)-1-Phenylpropyl]-4-(Hydroxymethyl)Phenol As As Fesoterodine Precursors 参考文献:World Intellectual Property Organization]
51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3 反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 70 °C 标题:The Lactol Route To Fesoterodine: An Amine-Promoted Friedel-Crafts Alkylation On Commercial Scale 作者:Dirat,Olivier; Bibb,Andrew J.; Burns,Colin M.; Checksfield,Graham D.; Dillon,Barry R.; Et Al 参考文献:Organic Process Research & Development 日期:2011 卷标:15(5) 页码:1010-1017]
51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3 反应条件:1.1 Solvents: Tetrahydrofuran; 50 - 55 °C; 6 H,25 - 30 °C; 30 °C -> 15 °C; 2 - 3 H,10 - 15 °C 标题:Method For Preparation Of Fesoterodine And Its Pharmaceutically Acceptable Salts For Treatment Of Urinary Incontinence 参考文献:World Intellectual Property Organization]
= 207679-81-0 + 51019-43-3 [标题:Reaction Conditions 标题:Process For The Production Of Benzopyran-2-Ol Derivatives 参考文献:United States]
51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3 反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 2 H,70 °C; 1 H,70 - 75 °C 标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Ylmethanol And (R)-2-[3-(Diisopropylamino)-1-Phenylpropyl]-4-(Hydroxymethyl)Phenol As Fesoterodine Precursors 参考文献:Italy]
51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3 反应条件:1.1 Solvents: Ethyl Acetate; 5 - 6 H,55 °C; 55 °C -> 30 °C; 25 - 30 °C 标题:Process For The Preparation Of Fesoterodine And Intermediates 参考文献:World Intellectual Property Organization]
= 207679-81-0 + 51019-43-3 [标题:Reaction Conditions 标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Yl-Methanol And (R)-Feso-Deacyl 参考文献:United States
(R)-[4-Benzyloxy-3-(3-Diisopropylamino-1-Phenyl-Propyl)-Phenyl]-Methanol Fumarate置于raney Nickel Sodium Carbonate,Sodium Hydroxide,氢气体系中,用 二氯甲烷,水,甲醇 用作溶剂,以59%的收率获得(R)-5-羟甲基托特罗定 参考文献: A Process For Preparing Fesoterodine[fr] Procédé De Préparation De Fésotérodine 标题: A Process For Preparing Fesoterodine[fr] Procédé De Préparation De Fésotérodine 摘要:本发明涉及一种改进的制备fesoterodine及其药用盐的方法.本发明特别涉及一种制备fesoterodine及其药用盐的方法,其中涉及使用和制备r(+)苄基托特罗定和r(+)-[4-苄氧基-3-(3-二异丙基氨基-1-苯基丙基)-苯基]-甲醇富马酸盐.
专利号:WO-2017137955-A1 优先权日:2016-02-14 标题:Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol 发明人:THOMBARE PRAVIN SAHADEV 权利人:CELESTIS PHARMACEUTICALS PVT LTD 摘要:The present invention relates to novel chiral 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (5) and racemic 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-amine () and its use in improved and industrially advantageous process for preparation of chiral and racemic form of 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol. Further, present invention relates to preparation of the same.
专利号:EP-1862449-A1 优先权日:2006-05-31 标 题 :A shortened synthesis of substituted hydroxymethyl phenols 发明人:BROWNE ROISIN; KIKELLY MICHAEL 权利人:SCHWARZ PHARMA LTD 摘要:The present disclosure relates to a process for the preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol or its phenolic monoesters or salts thereof, characterized by the steps of na) reacting a compound of formula (II)n nwith a mixture of MeMgCl and Mg in a solvent, nb) optionally reducing the temperature of the Grignard reagent to a lower temperature than in step a), and n nreacting the resulting Grignard reagent with an excess of a carbonate in a solvent, to obtain a compound of formula (III)n nwherein A is a C 1 -C 6 alkyl group, and then further reacting the compound of formula (III) in a known manner to obtain the desired end product.
专利号:US-8703996-B2 优先权日:2010-03-09 标题:Short synthesis of tolterodin, intermediates and metabolites 发明人:STERK DAMJAN 权利人:STERK DAMJAN; LEK PHARMACEUTICALS 摘要:A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.
专利号:US-9751828-B2 优先权日:2014-07-30 标题:Antimuscarinic compound having a low content of impurities 发明人:ALLEGRINI PIETRO; ATTOLINO EMANUELE; GRAZIOSI RENZO 权利人:DIPHARMA FRANCIS SRL 摘要:Substantially stable to degradation Fesoterodine fumarate, a process for its preparation and a process for the synthesis of specific degradation impurities of Fesoterodine fumarate are disclosed.
专利号:US-6809214-B2 优先权日:2000-06-14 标 题 :Shortened synthesis of 3,3-diarylpropylamine derivatives 发明人:MEESE CLAUS O 权利人:SANOL ARZNEI SCHWARZ GMBH 摘要:The invention relates to a method for producing derivatives of 3,3-diarylpropylamines of general formula (I) and sterically highly pure, stable intermediate products, and to their use for producing pharmaceutical compositions.
专利号:US-8344176-B2 优先权日:2006-05-31 标 题 :Synthesis of substituted hydroxymethyl phenols 发明人:BROWNE ROISIN; KILKELLY MICHAEL 权利人:SCHWARZ PHARMA LTD; BROWNE ROISIN; KILKELLY MICHAEL 摘要:The present disclosure relates to a process for the preparation of 2-(3 -diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol or its phenolic monoesters or salts thereof, characterized by the steps of a) reacting a compound of formula (II) with a mixture of a Grignard initiator and Mg in a solvent; b) optionally reducing the temperature of the Grignard reagent to a lower temperature than in step a), and reacting the resulting Grignard reagent with an excess of a carbonate in a solvent, to obtain a compound of formula (III) wherein A is a C 1 -C 6 alkyl, and the further reacting the compound of formula (III) in a known manner to obtain the desired end product.
1: Nilvebrant L, Gillberg PG, Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol Toxicol. 1997 Oct;81(4):169-72.